MAGE-1 and MAGE-3 tumor rejection antigens in human germ cell tumors

Modern Pathology

Volumn 12, Issue 10, 1999, Pages 974-978

  Cheville, John C ^a   Roche, Patrick C ^a  

^a MAYO CLINIC   (United States)

Author keywords

HLA; Lymphocyte; MAGE; Seminoma; Testis

Indexed keywords

FORMALDEHYDE; HLA ANTIGEN CLASS 1; MELANOMA ANTIGEN; MONOCLONAL ANTIBODY; PARAFFIN; TUMOR REJECTION ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; GERM CELL TUMOR; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; TESTIS TUMOR; TUMOR VOLUME;

ADULT; AGED; ANTIGENS, NEOPLASM; GERMINOMA; HUMANS; IMMUNOHISTOCHEMISTRY; LEYDIG CELL TUMOR; MALE; MIDDLE AGED; NEOPLASM PROTEINS; TESTICULAR NEOPLASMS; TESTIS;

EID: 0032827534     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gaugler B, Van den Eynde B, Van der Bruggen P, Romero P, Gaforio JJ, DePlean E, et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 1994;179:921-30.
2. Van der Bruggen P, Traversari C, Chomez P, Lurquin C, DePlean E, Van den Eynde B, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991;254:1643-7.
3. Traversari C, Van der Bruggen P, Luescher IF, Lurquin C, Chomez P, Van Pel A, et al. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 1992;176:1453-7.
4. Inoue H, Mori M, Li J, Mimori K, Honda M, Nakashima H, et al. Human esophageal carcinomas frequently express the tumor-rejection antigens of MAGE genes. Int J Cancer 1995; 63:523-6.
5. Gillespie AM, Rodgers S, Wilson AP, Tidy J, Rees RC, Coleman RE, et al. MAGE, BAGE, and GAGE. Tumor antigen expression in benign and malignant ovarian tissue. Br J Cancer 1998;78:816-21.
6. Quillien V, Raoul JL, Heresbach D, Collet B, Toujas L, Brasseur F. Expression of MAGE genes in esophageal squamous cell carcinoma. Anticancer Res 1997;17:387-91.
7. Mori M, Inoue H, Mimori K, Shibuta K, Baba K, Nakashima H, et al. Expression of MAGE genes in human colorectal carcinoma. Ann Surg 1996;224:183-8.
8. Gotoh K, Yatabe Y, Suguira T, Takagi K, Ogawa M, Takahashi T, et al. Frequency of MAGE-3 gene expression in HLA-A2 positive patients with non-small cell lung cancer. Lung Cancer 1998;20:117-25.
9. Patard JJ, Brasseur F, Gil-Diez S, Radvanyi F, Marchand M, Francois P, et al. Expression of MAGE genes in transitional cell carcinomas of the urinary bladder. Int J Cancer 1995;64: 60-4.
10. Russo V, Traversari C, Verrecchia A, Mottolese M, Natale PG, Bordignon C. Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for tumor antigen-specific immunotherapy. Int J Cancer 1995; 64:216-21.
11. Inoue H, Mori M, Honda M, Li J, Shibuta K, Mimori K, et al. The expression of tumor-rejection antigen "MAGE" genes in human gastric carcinoma. Gastroenterology 1995;109: 1522-5.
12. Takahashi K, Shichijo S, Noguchi M, Hirohata M, Itoh K. Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res 1995; 55:3478-82.
13. Chomez P, Williams R, DeBacker O, Boon T, Vennstrom B. The SMAGE gene family is expressed in post-meiotic spermatids during mouse germ cell differentiation. Immunogenetics 1995;43:97-100.
14. De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, DeSmet C, et al. Structure, chromosome localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994;40:360-9.
15. Tanaka F, Fujie T, Go H, Baba K, Mori M, Takesako K, et al. Efficient induction of antitumor cytotoxic T lymphocytes from a healthy donor using HLA-A2-restricted MAGE-3 peptide in vitro. Cancer Immunol Immunother 1997;44:21-6.
16. Marchand M, Weynants P, Rankin E, Arienti F, Belli F, Parmiani G, et al. Tumor regression responses in melanoma patients treated with peptide encoded by gene MAGE-3. Int J Cancer 1994;63:883-5.
17. Okamoto T, Kaneda Y, Yuzuki D, Huang SKS, Chi DDJ, Hoon DSB. Induction of antibody response to human tumor antigens by gene therapy using a fusigenic viral liposome vaccine. Gene Ther 1997;4:969-76.
18. Bell DA, Flotte TJ, Bhan AK. Immunohistochemical characterization of seminoma and inflammatory cell infiltrate. Hum Pathol 1987;18:511-20.
19. Wei YQ, Hang LB, Liu KF. In situ observations of inflammatory cell-tumor interaction in human seminomas (germinomas). Hum Pathol 1992;23:421-3.
20. Herman J, van der Bruggen P, Luescher IF, Mandruzzato S, Romero P, Thonnard J, et al. A peptide encoded by the human MAGE-3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Immunogenetics 1996;43:377-83.
21. Van der Bruggen P, Bastin J, Gajewski T, Coulie PG, Boel P, De Smet C, et al. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur J Immunol 1994;24:3038-43.
22. Natali PG, Nicotra MR, Bigotti A, Venture I, Marcenaro L, Giacomini P, et al. Selective changes in expression of HLA class I polymorphic determinants in human solid tumors. Proc Natl Acad Sci U S A 1989;86:6719-23.
23. Klein B, Klein T, Konichezky M, Nyska A, Livini E, Levine I, et al. The expression of HLA class I antigens in germ cell testicular cancer. Am J Clin Pathol 1990;93:202-7.
24. Tomita Y, Kimura M, Tanikawa T, Nishiyama T, Morishita H, Takeda M, et al. Immunohistochemical detection of intercellular adhesion molecule-1 (ICAM-1) and major histocompatibility complex class I antigens in seminoma. J Urol 1993; 149:659-63.
25. Janitz M, Fiszer D, Jaruzelsk J, Simon AK, Biro A, Sachs JA, et al. In situ localization of HLA class I mRNA in human testis. Exp Clin Immunogenet 1993;10:202-7.